CN111394868A - Anti-infection antibacterial fabric for infants and preparation method thereof - Google Patents

Anti-infection antibacterial fabric for infants and preparation method thereof Download PDF

Info

Publication number
CN111394868A
CN111394868A CN202010192918.6A CN202010192918A CN111394868A CN 111394868 A CN111394868 A CN 111394868A CN 202010192918 A CN202010192918 A CN 202010192918A CN 111394868 A CN111394868 A CN 111394868A
Authority
CN
China
Prior art keywords
infection
preparation
fabric
infants
furan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202010192918.6A
Other languages
Chinese (zh)
Inventor
张海军
李洪霞
董晓蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010192918.6A priority Critical patent/CN111394868A/en
Publication of CN111394868A publication Critical patent/CN111394868A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B1/00Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B1/14Other fabrics or articles characterised primarily by the use of particular thread materials
    • D04B1/16Other fabrics or articles characterised primarily by the use of particular thread materials synthetic threads
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48Polymers modified by chemical after-treatment
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/08Melt spinning methods
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/88Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/90Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyamides
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/02Yarns or threads characterised by the material or by the materials from which they are made
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/10Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
    • D06M13/184Carboxylic acids; Anhydrides, halides or salts thereof
    • D06M13/192Polycarboxylic acids; Anhydrides, halides or salts thereof
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2101/00Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
    • D06M2101/16Synthetic fibres, other than mineral fibres
    • D06M2101/30Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M2101/34Polyamides
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2331/00Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
    • D10B2331/02Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyamides

Landscapes

  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Artificial Filaments (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

The invention discloses a preparation method of an anti-infection antibacterial fabric for infants, which is characterized by comprising the following steps of: step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide; step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide; step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol modification intermediate; step S4, preparing functional yarns; step S5, crosslinking and curing; and step S6, weaving the fabric. The invention also discloses the anti-infection and anti-bacterial fabric for the infants, which is prepared by the preparation method of the anti-infection and anti-bacterial fabric for the infants. The anti-infection and antibacterial fabric for infants disclosed by the invention has the advantages of remarkable anti-infection and antibacterial effects, good antibacterial broad spectrum, excellent comprehensive performance, and excellent moisture absorption and sweat releasing properties, water resistance, flame retardance, ultraviolet aging resistance and wrinkle resistance.

Description

Anti-infection antibacterial fabric for infants and preparation method thereof
Technical Field
The invention relates to the technical field of textiles, in particular to an anti-infection and antibacterial fabric for infants and a preparation method thereof.
Background
The skin of infants and young children differs significantly from the skin of adults in structure, function and composition. It is generally accepted that the skin structure and function of infants are in a state of continuous growth and perfection for at least one year after birth. The skin of infants is thinner than the horny layer of adult skin, and the horny cells are small, and are more fragile, sensitive and easily stimulated. As the garment fabric clinging to the skin of a human body, the comfort and the health care function are important indexes for measuring the quality of the fabric, and the selection of the proper garment fabric is very important for infants who cannot express the preference of the infants in language.
The ideal fabric for infants needs to have excellent biocompatibility, air permeability, moisture dispersion, heat retention, handfeel softness, infection-preventing antibacterial property, washing resistance, sun resistance and mildew resistance at the same time. In the prior art, the research and development of fabrics mainly focuses on comfort and beauty, but in life, infants inevitably contact with various microorganisms such as bacteria and fungi, the microorganisms can rapidly breed under proper external conditions, diseases can be spread through contact and the like, and the health and normal life of the infants are influenced. Therefore, the anti-infection and antibacterial functions of the fabric for infants are certainly improved.
In order to improve the anti-infection and antibacterial functions of the fabric, the mainstream treatment mode in the market at present is to add an antibacterial agent into a fabric base material; however, the compatibility problem between the antibacterial agent and the base material leads to poor performance stability, and the antibacterial agent in the prior art is often single in function, poor in broad-spectrum property and limited in antibacterial effect. In addition, the infection-preventing antibacterial fabric for infants on the market has the defects of poor moisture absorption and sweat releasing effects, and further improved waterproofness, flame retardance, ultraviolet aging resistance and wrinkle resistance.
Chinese patent document CN103255538A discloses an anti-ultraviolet and anti-bacterial fabric and a preparation process thereof, the prior art comprises, by weight, 10-15% of viscose negative ion functional fibers, 10-15% of soybean protein fibers, 20-30% of hemp fibers, 5-10% of wool fibers, 5-10% of nano bamboo charcoal fibers, 10-15% of chitin fibers, 2-5% of nano silver ion fibers, 4-6% of an anti-ultraviolet finishing agent and 2-4% of a mosquito repellent agent, and the fabric in the prior art has the effects of ultraviolet resistance, air permeability improvement and bacteriostasis and mosquito repelling. However, the moisture-permeable and sweat-permeable fabric is not ideal in moisture permeability, durability and wrinkle resistance.
Therefore, a more effective method is needed, and the prepared anti-infection and anti-bacterial fabric for infants has the advantages of remarkable anti-infection and anti-bacterial effect, good antibacterial broad spectrum, good comprehensive performance, and excellent moisture absorption and sweat releasing performance, water resistance, flame retardance, ultraviolet aging resistance and wrinkle resistance, and has very important significance.
Disclosure of Invention
In view of the above, the invention aims to provide an anti-infection and antibacterial fabric for infants and a preparation method thereof, wherein the preparation method has the advantages of simple process, easily obtained preparation raw materials, low requirements on reaction conditions and equipment, and high social value, economic value and ecological value; the anti-infection and antibacterial fabric for infants prepared by the preparation method has the advantages of remarkable anti-infection and antibacterial effects, good antibacterial broad spectrum, good comprehensive performance, and excellent moisture absorption and sweat releasing properties, water resistance, flame retardance, ultraviolet aging resistance and wrinkle resistance.
In order to achieve the purpose, the invention adopts the technical scheme that:
a preparation method of an anti-infection antibacterial fabric for infants is characterized by comprising the following steps:
step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide: adding 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, thiocarbohydrazide polyamide and a catalyst into a high boiling point solvent, stirring for 1-2 hours at 80-90 ℃ to obtain a reaction mixture, transferring the reaction mixture into a high-pressure reaction kettle, replacing air in the kettle with nitrogen or inert gas, keeping the temperature in the high-pressure reaction kettle at 260 ℃ and the pressure at 0.8-1.5MPa, stirring for 3-5 hours, slowly exhausting gas within 1-2 hours and reducing the pressure to 0.1-0.4MPa, simultaneously heating the temperature in the high-pressure reaction kettle to 290 ℃ and stirring for 1-3 hours, finally controlling the temperature to be between 230 ℃ and 250 ℃ under the vacuum condition, stirring for 18-24 hours, cooling to room temperature after the reaction is finished, precipitating in water, washing the precipitated polymer with ethanol for 3-7 times, and removing ethanol by rotary evaporation to obtain polyamide based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine;
step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazohydrazine polyamide: dissolving polyamide based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine and 4-chloromethyl-2- (2-furyl) -1, 3-thiazole in N-methylpyrrolidone, adding an alkaline catalyst, stirring and reacting for 6-8 hours at 40-60 ℃, filtering to remove insoluble substances, and performing rotary evaporation to remove the N-methylpyrrolidone to obtain an intermediate product;
step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol-modified intermediate: adding the intermediate product prepared in the step S2 and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol into N, N-dimethylformamide, stirring and reacting at 30-50 ℃ for 6-8 hours, and then removing the N, N-dimethylformamide by rotary evaporation to obtain an ionic condensation polymer;
step S4, preparation of functional yarn: uniformly mixing the ionic polycondensate prepared in the step S3, mustard powder and a coupling agent to form a mixed material, adding the mixed material into a double-screw extruder to extrude and granulate, and performing melt spinning to prepare functional fibers; then, the functional fiber is sequentially subjected to blowing, opening, drawing, roving and spinning to prepare functional yarn;
step S5, crosslinking and curing: spraying 10-15% by mass of dimethyl sulfoxide solution of 1, 3-adamantane diacetic acid on the functional yarn prepared in the step S4, and then placing the functional yarn in a vacuum drying oven at 100-110 ℃ for drying to constant weight to obtain a cross-linked functional yarn;
step S6, weaving the fabric: weaving the cross-linking type functional yarn prepared in the step S5 through a circular knitting machine to obtain grey cloth; then dyeing, pre-setting, upper soft dehydrating and drying the grey cloth in sequence to obtain the fabric.
Preferably, the molar ratio of the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, the thiocarbohydrazide polyamide, the catalyst and the high-boiling-point solvent in the step S1 is 1:1 (0.8-1.2): 10-20.
Preferably, the catalyst is at least one of thiophosphonate, phosphorous acid and thiophosphoryl amide; the high boiling point solvent is at least one of N, N-dimethylformamide, N-dimethylacetamide and N-methylpyrrolidone; the inert gas is one of helium, neon and argon.
Preferably, the molar ratio based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine polyamide, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole, N-methylpyrrolidone, basic catalyst described in step S2 is 1:4 (15-20): (2-3).
Preferably, the alkaline catalyst is at least one of sodium carbonate, potassium hydroxide and sodium hydroxide.
Preferably, the molar ratio of the intermediate product, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol and N, N-dimethylformamide in step S3 is 1:2 (10-15).
Preferably, the mass ratio of the ionic polycondensate, the mustard powder and the coupling agent in the step S4 is 1:0.1 (0.02-0.05); the coupling agent is at least one of a silane coupling agent KH550, a silane coupling agent KH560 and a silane coupling agent KH 570.
Preferably, the extrusion granulation extrusion temperature is 215-225 ℃, and the screw rotation speed is 900-1000 r/min; the melt spinning process comprises the following steps: the spinning temperature is 275 ℃ plus 295 ℃, the spinning speed is 1800 ℃ plus 2400m/min, the drawing temperature is 60-80 ℃, and the total drawing ratio is 1.5-3.5.
Preferably, the mass ratio of the functional yarn and the dimethyl sulfoxide solution of the 1, 3-adamantane diacetic acid in the step S5 is 1 (0.05-0.1).
The invention also aims to provide the anti-infection and anti-bacterial fabric for the infants, which is prepared according to the preparation method of the anti-infection and anti-bacterial fabric for the infants.
Adopt the produced beneficial effect of above-mentioned technical scheme to lie in:
(1) the preparation method of the infection-preventing antibacterial fabric for infants, provided by the invention, has the advantages of simple process, easily obtained preparation raw materials, low requirements on reaction conditions and equipment, and high social value, economic value and ecological value.
(2) The anti-infection antibacterial fabric for infants overcomes the defects that an antibacterial fabric in the prior art is not strong in antibacterial effect, not strong in antibacterial broad spectrum, not good in performance stability, and needs to be further improved in moisture absorption and sweat releasing effect, water resistance, flame resistance, ultraviolet aging resistance and wrinkle resistance.
(3) According to the anti-infection antibacterial fabric for infants, provided by the invention, 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide is taken as a base material, furan and thiosemicarbazide are introduced into a polymer main chain, and a synergistic effect is achieved, so that the anti-infection antibacterial fabric has high anti-virus and antibacterial effects; the molecular chain is introduced with fluorine and polyamide structures, so that the comprehensive performance of the fabric can be effectively improved, and the durability and the antibacterial and anti-infection performance can be further improved by introducing thiazole, oxadiazole and phenol structures and a synergistic effect through the modification of 4-chloromethyl-2- (2-furyl) -1, 3-thiazole and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol.
(4) According to the anti-infection antibacterial fabric for infants, 1, 3-adamantane diacetic acid is used as a cross-linking agent and is connected with cations on a polymer molecular chain through ionic bonds to form an ionic cross-linking three-dimensional network structure, so that the comprehensive performance of the fabric can be effectively improved; and the adamantane structure can emit fragrance, the fragrance is lasting, and the practicability of the fabric is effectively improved.
Detailed Description
In order to make the technical solutions of the present invention better understood and make the above features, objects, and advantages of the present invention more comprehensible, the present invention is further described with reference to the following examples. The examples are intended to illustrate the invention only and are not intended to limit the scope of the invention.
In the embodiment of the invention, the raw materials are all purchased commercially.
Example 1
A preparation method of an anti-infection antibacterial fabric for infants is characterized by comprising the following steps:
step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide: adding 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, thiocarbazoic polyamide and thiophosphonate into N, N-dimethylformamide, stirring for 1 hour at 80 ℃ to obtain a reaction mixture, then transferring the reaction mixture into a high-pressure reaction kettle, replacing the air in the kettle with nitrogen, keeping the temperature and the pressure in the high-pressure reaction kettle at 240 ℃ and 0.8MPa, stirring for reaction for 3 hours, then slowly exhausting and reducing the pressure to 0.1MPa within 1 hour, simultaneously raising the temperature of the high-pressure reaction kettle to 270 ℃, stirring for reaction for 1 hour, finally controlling the temperature to 230 ℃ under vacuum conditions, stirring for reaction for 18 hours, cooling to room temperature after the reaction is finished, precipitating in water, washing the precipitated polymer for 3 times with ethanol, and then rotationally evaporating to remove the ethanol to obtain the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide; the molar ratio of the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid to the thiocarbohydrazide polyamide to the thiophosphonate to the N, N-dimethylformamide is 1:1:0.8: 10;
step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazohydrazine polyamide: dissolving 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide and 4-chloromethyl-2- (2-furyl) -1, 3-thiazole in N-methylpyrrolidone, adding sodium carbonate, stirring and reacting at 40 ℃ for 6 hours, filtering to remove insoluble substances, and performing rotary evaporation to remove the N-methylpyrrolidone to obtain an intermediate product; the molar ratio of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine polyamide, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole, N-methylpyrrolidone and sodium carbonate is 1:4:15: 2;
step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol-modified intermediate: adding the intermediate product prepared in the step S2 and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol into N, N-dimethylformamide, stirring and reacting at 30 ℃ for 6 hours, and then performing rotary evaporation to remove the N, N-dimethylformamide to obtain an ionic condensation polymer; the molar ratio of the intermediate product to 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol to N, N-dimethylformamide is 1:2: 10;
step S4, preparation of functional yarn: uniformly mixing the ionic polycondensate prepared in the step S3, mustard powder and a silane coupling agent KH550 to form a mixed material, adding the mixed material into a double-screw extruder, extruding and granulating, and performing melt spinning to prepare functional fibers; then, the functional fiber is sequentially subjected to blowing, opening, drawing, roving and spinning to prepare functional yarn; the mass ratio of the ionic polycondensate to the mustard powder to the silane coupling agent KH550 is 1:0.1: 0.02; the extrusion granulation extrusion temperature is 215 ℃, and the screw rotation speed is 900 r/min; the melt spinning process comprises the following steps: the spinning temperature is 275 ℃, the spinning speed is 1800m/min, the drawing temperature is 60 ℃, and the total drawing ratio is 1.5;
step S5, crosslinking and curing: spraying a dimethyl sulfoxide solution of 1, 3-adamantane diacetic acid with the mass fraction of 10% on the functional yarn prepared in the step S4, and then placing the functional yarn in a vacuum drying oven to dry the functional yarn to constant weight at 100 ℃ to obtain cross-linked functional yarn; the mass ratio of the functional yarn to the dimethyl sulfoxide solution of the 1, 3-adamantane diacetic acid is 1: 0.05;
step S6, weaving the fabric: weaving the cross-linking type functional yarn prepared in the step S5 through a circular knitting machine to obtain grey cloth; then dyeing, pre-setting, upper soft dehydrating and drying the grey cloth in sequence to obtain the fabric.
The anti-infection and anti-bacterial fabric for the infants is prepared according to the preparation method of the anti-infection and anti-bacterial fabric for the infants.
Example 2
A preparation method of an anti-infection antibacterial fabric for infants is characterized by comprising the following steps:
step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide: adding 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, thiocarbazoic polyamide and phosphorous acid into N, N-dimethylacetamide, stirring for 1.2 hours at 82 ℃ to obtain a reaction mixture, transferring the reaction mixture into a high-pressure reaction kettle, replacing air in the kettle with helium, keeping the temperature in the high-pressure reaction kettle at 245 ℃ and the pressure at 0.9MPa, stirring for 3.5 hours, slowly exhausting and reducing the pressure to 0.2MPa within 1.2 hours, simultaneously heating the temperature in the high-pressure reaction kettle to 275 ℃, stirring for 1.5 hours, finally controlling the temperature to be 235 ℃ under vacuum conditions, stirring for 19 hours, cooling to room temperature after the reaction is finished, precipitating in water, washing the precipitated polymer with ethanol for 4 times, then carrying out rotary evaporation to remove the ethanol to obtain the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide; the molar ratio of the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid to the thiocarbohydrazide polyamide to the phosphorous acid to the N, N-dimethylacetamide is 1:1:0.9: 12;
step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazohydrazine polyamide: dissolving polyamide based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine and 4-chloromethyl-2- (2-furyl) -1, 3-thiazole in N-methylpyrrolidone, adding potassium carbonate, stirring and reacting at 45 ℃ for 6.5 hours, filtering to remove insoluble substances, and performing rotary evaporation to remove the N-methylpyrrolidone to obtain an intermediate product; the molar ratio of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine based polyamide, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole, N-methylpyrrolidone and potassium carbonate is 1:4:16: 2.2;
step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol-modified intermediate: adding the intermediate product prepared in the step S2 and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol into N, N-dimethylformamide, stirring and reacting at 35 ℃ for 6.5 hours, and then removing the N, N-dimethylformamide by rotary evaporation to obtain an ionic condensation polymer; the molar ratio of the intermediate product to 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol to N, N-dimethylformamide is 1:2: 12;
step S4, preparation of functional yarn: uniformly mixing the ionic polycondensate prepared in the step S3, mustard powder and a silane coupling agent KH560 to form a mixed material, adding the mixed material into a double-screw extruder, extruding and granulating, and performing melt spinning to prepare functional fibers; then, the functional fiber is sequentially subjected to blowing, opening, drawing, roving and spinning to prepare functional yarn; the mass ratio of the ionic polycondensate to the mustard powder to the silane coupling agent KH560 is 1:0.1: 0.03; the extrusion granulation extrusion temperature is 217 ℃, and the screw rotation speed is 920 r/min; the melt spinning process comprises the following steps: the spinning temperature is 280 ℃, the spinning speed is 1900m/min, the drawing temperature is 65 ℃, and the total drawing ratio is 2;
step S5, crosslinking and curing: spraying a dimethyl sulfoxide solution of 1, 3-adamantane diacetic acid with the mass fraction of 11% on the functional yarn prepared in the step S4, and then placing the functional yarn in a vacuum drying oven to dry the functional yarn to constant weight at 103 ℃ to obtain a cross-linked functional yarn; the mass ratio of the functional yarn to the dimethyl sulfoxide solution of the 1, 3-adamantane diacetic acid is 1: 0.06;
step S6, weaving the fabric: weaving the cross-linking type functional yarn prepared in the step S5 through a circular knitting machine to obtain grey cloth; then dyeing, pre-setting, upper soft dehydrating and drying the grey cloth in sequence to obtain the fabric.
The anti-infection and anti-bacterial fabric for the infants is prepared according to the preparation method of the anti-infection and anti-bacterial fabric for the infants.
Example 3
A preparation method of an anti-infection antibacterial fabric for infants is characterized by comprising the following steps:
step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide: adding 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, thiocarbohydrazide polyamide and thiophosphoramide into N-methylpyrrolidone, stirring for 1.5 hours at 85 ℃ to obtain a reaction mixture, transferring the reaction mixture into a high-pressure reaction kettle, replacing air in the kettle with neon, keeping the temperature and the pressure in the high-pressure reaction kettle at 250 ℃ and 1MPa, stirring for reaction for 4 hours, slowly exhausting air and reducing the pressure to 0.25MPa within 1.5 hours, simultaneously raising the temperature in the high-pressure reaction kettle to 280 ℃, stirring for reaction for 2 hours, finally controlling the temperature to 240 ℃ under a vacuum condition, stirring for reaction for 20 hours, cooling to room temperature after the reaction is finished, precipitating in water, washing the precipitated polymer with ethanol for 5 times, evaporating to remove the ethanol to obtain the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide; the molar ratio of the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid to the thiocarbohydrazide polyamide to the thiophosphoramide to the N-methylpyrrolidone is 1:1:1: 15;
step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazohydrazine polyamide: dissolving 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide and 4-chloromethyl-2- (2-furyl) -1, 3-thiazole in N-methylpyrrolidone, adding potassium hydroxide, stirring at 50 ℃ for 7 hours, filtering to remove insoluble substances, and performing rotary evaporation to remove the N-methylpyrrolidone to obtain an intermediate product; the molar ratio of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine polyamide, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole, N-methylpyrrolidone and potassium hydroxide is 1:4:17: 2.5;
step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol-modified intermediate: adding the intermediate product prepared in the step S2 and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol into N, N-dimethylformamide, stirring and reacting at 40 ℃ for 7 hours, and then removing the N, N-dimethylformamide by rotary evaporation to obtain an ionic condensation polymer; the molar ratio of the intermediate product to 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol to N, N-dimethylformamide is 1:2: 13;
step S4, preparation of functional yarn: uniformly mixing the ionic polycondensate prepared in the step S3, mustard powder and a silane coupling agent KH570 to form a mixed material, adding the mixed material into a double-screw extruder, extruding and granulating, and performing melt spinning to prepare functional fibers; then, the functional fiber is sequentially subjected to blowing, opening, drawing, roving and spinning to prepare functional yarn; the mass ratio of the ionic polycondensate to the mustard powder to the silane coupling agent KH570 is 1:0.1: 0.035; the extrusion granulation extrusion temperature is 220 ℃, and the screw rotation speed is 950 r/min; the melt spinning process comprises the following steps: the spinning temperature is 285 ℃, the spinning speed is 2100m/min, the drawing temperature is 70 ℃, and the total drawing ratio is 2.5;
step S5, crosslinking and curing: spraying a dimethyl sulfoxide solution of 13 mass percent of 1, 3-adamantane diacetic acid on the functional yarn prepared in the step S4, and then drying the functional yarn in a vacuum drying oven at 105 ℃ to constant weight to obtain a cross-linked functional yarn; the mass ratio of the functional yarn to the dimethyl sulfoxide solution of the 1, 3-adamantane diacetic acid is 1: 0.08;
step S6, weaving the fabric: weaving the cross-linking type functional yarn prepared in the step S5 through a circular knitting machine to obtain grey cloth; then dyeing, pre-setting, upper soft dehydrating and drying the grey cloth in sequence to obtain the fabric.
The anti-infection and anti-bacterial fabric for the infants is prepared according to the preparation method of the anti-infection and anti-bacterial fabric for the infants.
Example 4
A preparation method of an anti-infection antibacterial fabric for infants is characterized by comprising the following steps:
step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide: adding 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, thiocarbohydrazide polyamide and a catalyst into a high-boiling-point solvent, stirring at 88 deg.C for 1.9 hr to obtain a reaction mixture, transferring the reaction mixture into a high-pressure reaction kettle, replacing air in the autoclave with argon, maintaining the temperature at 255 ℃ and the pressure at 1.4MPa in the high-pressure reaction kettle, stirring and reacting for 4.7h, then slowly exhausting gas and reducing the pressure to 0.35MPa within 1.9 hours, simultaneously raising the temperature in the high-pressure reaction kettle to 286 ℃, stirring and reacting for 2.7 hours, finally, under the vacuum condition, controlling the temperature between 247 ℃, stirring and reacting for 23 hours, cooling to room temperature after the reaction is finished, precipitating in water, washing the precipitated polymer with ethanol for 6 times, and removing ethanol by rotary evaporation to obtain polyamide based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine; the molar ratio of the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid to the thiocarbohydrazide polyamide to the catalyst to the high-boiling-point solvent is 1:1:1.1: 19; the catalyst is formed by mixing thiophosphonate, phosphorous acid and thiophosphoryl amide according to the mass ratio of 1:2: 3; the high-boiling-point solvent is formed by mixing N, N-dimethylformamide, N-dimethylacetamide and N-methylpyrrolidone according to a mass ratio of 2:1: 2;
step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazohydrazine polyamide: dissolving polyamide based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine and 4-chloromethyl-2- (2-furyl) -1, 3-thiazole in N-methylpyrrolidone, adding an alkaline catalyst, stirring and reacting for 7.8 hours at 57 ℃, filtering to remove insoluble substances, and performing rotary evaporation to remove the N-methylpyrrolidone to obtain an intermediate product; the molar ratio of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine based polyamide, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole, N-methylpyrrolidone and basic catalyst is 1:4:19: 2.8; the alkaline catalyst is formed by mixing sodium carbonate, potassium hydroxide and sodium hydroxide according to the mass ratio of 1:3:2: 2;
step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol-modified intermediate: adding the intermediate product prepared in the step S2 and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol into N, N-dimethylformamide, stirring and reacting at 47 ℃ for 7.8 hours, and then removing the N, N-dimethylformamide by rotary evaporation to obtain an ionic condensation polymer; the molar ratio of the intermediate product to 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol to N, N-dimethylformamide is 1:2: 14;
step S4, preparation of functional yarn: uniformly mixing the ionic polycondensate prepared in the step S3, mustard powder and a coupling agent to form a mixed material, adding the mixed material into a double-screw extruder to extrude and granulate, and performing melt spinning to prepare functional fibers; then, the functional fiber is sequentially subjected to blowing, opening, drawing, roving and spinning to prepare functional yarn; the mass ratio of the ionic polycondensate to the mustard powder to the coupling agent is 1:0.1: 0.045; the coupling agent is formed by mixing a silane coupling agent KH550, a silane coupling agent KH560 and a silane coupling agent KH570 according to the mass ratio of 1:3: 5; the extrusion granulation extrusion temperature is 223 ℃, and the screw rotation speed is 990 r/min; the melt spinning process comprises the following steps: the spinning temperature is 292 ℃, the spinning speed is 2300m/min, the drawing temperature is 76 ℃, and the total drawing ratio is 3.2;
step S5, crosslinking and curing: spraying a dimethyl sulfoxide solution of 1, 3-adamantane diacetic acid with the mass fraction of 14% on the functional yarn prepared in the step S4, and then drying the functional yarn in a vacuum drying oven at 108 ℃ to constant weight to obtain a cross-linked functional yarn; the mass ratio of the functional yarn to the dimethyl sulfoxide solution of the 1, 3-adamantane diacetic acid is 1: 0.09;
step S6, weaving the fabric: weaving the cross-linking type functional yarn prepared in the step S5 through a circular knitting machine to obtain grey cloth; then dyeing, pre-setting, upper soft dehydrating and drying the grey cloth in sequence to obtain the fabric.
The anti-infection and anti-bacterial fabric for the infants is prepared according to the preparation method of the anti-infection and anti-bacterial fabric for the infants.
Example 5
A preparation method of an anti-infection antibacterial fabric for infants is characterized by comprising the following steps:
step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide: adding 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, thiocarbazoic polyamide and thiophosphonate into N, N-dimethylacetamide, stirring for 2 hours at 90 ℃ to obtain a reaction mixture, transferring the reaction mixture into a high-pressure reaction kettle, replacing air in the kettle with nitrogen, keeping the temperature and the pressure in the high-pressure reaction kettle at 260 ℃ and 1.5MPa, stirring for 5 hours, slowly exhausting and reducing the pressure to 0.4MPa within 2 hours, simultaneously heating the temperature of the high-pressure reaction kettle to 290 ℃, stirring for 3 hours, finally controlling the temperature to 250 ℃ under vacuum conditions, stirring for 24 hours, cooling to room temperature after the reaction is finished, precipitating in water, washing the precipitated polymer for 7 times with ethanol, and rotationally evaporating to remove the ethanol to obtain the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide; the molar ratio of the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid to the thiocarbohydrazide polyamide to the thiophosphonate to the N, N-dimethylacetamide is 1:1:1.2: 20;
step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazohydrazine polyamide: dissolving 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic acid polyamide and 4-chloromethyl-2- (2-furyl) -1, 3-thiazole in N-methylpyrrolidone, adding sodium hydroxide, stirring and reacting at 60 ℃ for 8 hours, filtering to remove insoluble substances, and performing rotary evaporation to remove the N-methylpyrrolidone to obtain an intermediate product; the molar ratio of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine polyamide, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole, N-methylpyrrolidone and sodium hydroxide is 1:4:20: 3;
step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol-modified intermediate: adding the intermediate product prepared in the step S2 and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol into N, N-dimethylformamide, stirring and reacting at 50 ℃ for 8 hours, and then removing the N, N-dimethylformamide by rotary evaporation to obtain an ionic condensation polymer; the molar ratio of the intermediate product to 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol to N, N-dimethylformamide is 1:2: 15;
step S4, preparation of functional yarn: uniformly mixing the ionic polycondensate prepared in the step S3, mustard powder and a silane coupling agent KH550 to form a mixed material, adding the mixed material into a double-screw extruder, extruding and granulating, and performing melt spinning to prepare functional fibers; then, the functional fiber is sequentially subjected to blowing, opening, drawing, roving and spinning to prepare functional yarn; the mass ratio of the ionic polycondensate to the mustard powder to the silane coupling agent KH550 is 1:0.1: 0.05; the extrusion granulation extrusion temperature is 225 ℃, and the screw rotation speed is 1000 r/min; the melt spinning process comprises the following steps: the spinning temperature is 295 ℃, the spinning speed is 2400m/min, the drawing temperature is 80 ℃, and the total drawing ratio is 3.5;
step S5, crosslinking and curing: spraying a dimethyl sulfoxide solution of 1, 3-adamantane diacetic acid with the mass fraction of 15% on the functional yarn prepared in the step S4, and then placing the functional yarn in a vacuum drying oven to dry the functional yarn to constant weight at 110 ℃ to obtain a cross-linked functional yarn; the mass ratio of the functional yarn to the dimethyl sulfoxide solution of the 1, 3-adamantane diacetic acid is 1: 0.1;
step S6, weaving the fabric: weaving the cross-linking type functional yarn prepared in the step S5 through a circular knitting machine to obtain grey cloth; then dyeing, pre-setting, upper soft dehydrating and drying the grey cloth in sequence to obtain the fabric.
The anti-infection and anti-bacterial fabric for the infants is prepared according to the preparation method of the anti-infection and anti-bacterial fabric for the infants.
Comparative example 1
This example provides an anti-infective fabric for infants, which has a formulation and a preparation method substantially the same as those of example 1, except that the modification of 4-chloromethyl-2- (2-furyl) -1, 3-thiazole based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine polyamide is not performed in the step S2.
Comparative example 2
This example provides an anti-infection and antibacterial fabric for infants, which has a formulation and a preparation method substantially the same as those of example 1, except that no intermediate product modified by 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol is used in step S3.
Comparative example 3
The present example provides an anti-infection and antibacterial fabric for infants, which has a formula and a preparation method substantially the same as those of example 1, except that step S5, crosslinking and curing are not performed.
Comparative example 4
The present example provides an anti-infection and anti-bacterial fabric for infants, which has a formula and a preparation method substantially the same as those of example 1, except that mustard powder is not added.
In order to further illustrate the beneficial technical effects of the embodiment of the invention, the infant anti-infection and antibacterial fabric described in the embodiments 1 to 5 and the comparative examples 1 to 4 is subjected to a performance test, the test results are shown in table 1, and the test method is as follows:
(1) air permeability: according to GB/T5453-1997 determination of the air permeability of textile fabrics.
(2) Drapability testing: the test was conducted with reference to FZ/T01045-1996 using a fabric drape performance tester model YG811E supplied by Wuhan national instruments Inc.; the samples were conditioned for 24 hours at a temperature of 20 ℃ and a relative humidity of 65% before the test.
(3) And (3) antibacterial property: the antibacterial performance of the textile is evaluated by the national standard GB/T20944.3-2008 part 3: the oscillating method is used for quantitatively testing the antibacterial property of the escherichia coli, and the antibacterial rate of the escherichia coli after being washed for 30 times is tested.
(4) Anti-pilling test: according to GB/T4802-1-2008, a circular trajectory method is adopted for testing, wherein the pressure is 590N, the fluffing times are 190 times, and the pilling times are 150 times.
TABLE 1
Item Air permeability Coefficient of pendancy Pilling resistance rating Antibacterial rate after washing for 30 times
Unit of mm/s Stage
Example 1 58.5 6.15 4 94.3
Example 2 58.8 6.11 5 94.5
Example 3 59.1 6.08 5 94.9
Example 4 59.4 6.04 5 95.4
Example 5 59.9 6.00 5 95.7
Comparative example 1 57.9 7.16 4 91.2
Comparative example 2 58.1 7.12 4 90.8
Comparative example 3 58.7 7.20 4 94.0
Comparative example 4 58.3 6.42 4 88.6
As can be seen from table 1, the infection-preventing and antibacterial fabric for infants disclosed by the invention has more excellent air permeability, antibacterial property, pilling resistance and draping property, which are the result of the synergistic effect of each step of each component.
The foregoing shows and describes the general principles and broad features of the present invention and advantages thereof. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the specification and illustrated only to illustrate the principle of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the present invention, which fall within the scope of the invention as claimed. The scope of the invention is defined by the appended claims and equivalents thereof.

Claims (10)

1. A preparation method of an anti-infection antibacterial fabric for infants is characterized by comprising the following steps:
step S1, preparation of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbohydrazide-based polyamide: adding 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, thiocarbohydrazide polyamide and a catalyst into a high boiling point solvent, stirring for 1-2 hours at 80-90 ℃ to obtain a reaction mixture, transferring the reaction mixture into a high-pressure reaction kettle, replacing air in the kettle with nitrogen or inert gas, keeping the temperature in the high-pressure reaction kettle at 260 ℃ and the pressure at 0.8-1.5MPa, stirring for 3-5 hours, slowly exhausting gas within 1-2 hours and reducing the pressure to 0.1-0.4MPa, simultaneously heating the temperature in the high-pressure reaction kettle to 290 ℃ and stirring for 1-3 hours, finally controlling the temperature to be between 230 ℃ and 250 ℃ under the vacuum condition, stirring for 18-24 hours, cooling to room temperature after the reaction is finished, precipitating in water, washing the precipitated polymer with ethanol for 3-7 times, and removing ethanol by rotary evaporation to obtain polyamide based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine;
step S2, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole modification based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazohydrazine polyamide: dissolving polyamide based on 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine and 4-chloromethyl-2- (2-furyl) -1, 3-thiazole in N-methylpyrrolidone, adding an alkaline catalyst, stirring and reacting for 6-8 hours at 40-60 ℃, filtering to remove insoluble substances, and performing rotary evaporation to remove the N-methylpyrrolidone to obtain an intermediate product;
step S3, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol-modified intermediate: adding the intermediate product prepared in the step S2 and 2- [5- (chloromethyl) -1,2, 4-oxadiazole-3-yl ] -phenol into N, N-dimethylformamide, stirring and reacting at 30-50 ℃ for 6-8 hours, and then removing the N, N-dimethylformamide by rotary evaporation to obtain an ionic condensation polymer;
step S4, preparation of functional yarn: uniformly mixing the ionic polycondensate prepared in the step S3, mustard powder and a coupling agent to form a mixed material, adding the mixed material into a double-screw extruder to extrude and granulate, and performing melt spinning to prepare functional fibers; then, the functional fiber is sequentially subjected to blowing, opening, drawing, roving and spinning to prepare functional yarn;
step S5, crosslinking and curing: spraying 10-15% by mass of dimethyl sulfoxide solution of 1, 3-adamantane diacetic acid on the functional yarn prepared in the step S4, and then placing the functional yarn in a vacuum drying oven at 100-110 ℃ for drying to constant weight to obtain a cross-linked functional yarn;
step S6, weaving the fabric: weaving the cross-linking type functional yarn prepared in the step S5 through a circular knitting machine to obtain grey cloth; then dyeing, pre-setting, upper soft dehydrating and drying the grey cloth in sequence to obtain the fabric.
2. The method for preparing an anti-infection and antibacterial fabric for infants according to claim 1, wherein the molar ratio of the 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid, the thiocarbohydrazide polyamide, the catalyst and the high-boiling-point solvent in step S1 is 1:1 (0.8-1.2): 10-20).
3. The preparation method of the anti-infection and antibacterial fabric for infants according to claim 1, wherein the catalyst is at least one of thiophosphonate, phosphorous acid and thiophosphoramide; the high boiling point solvent is at least one of N, N-dimethylformamide, N-dimethylacetamide and N-methylpyrrolidone; the inert gas is one of helium, neon and argon.
4. The method for preparing an anti-infection and antibacterial fabric for infants according to claim 1, wherein the molar ratio of 2- (trifluoromethyl) furan-3, 4-dicarboxylic acid/thiocarbazoic hydrazine polyamide, 4-chloromethyl-2- (2-furyl) -1, 3-thiazole, N-methylpyrrolidone and alkaline catalyst in step S2 is 1:4 (15-20): (2-3).
5. The preparation method of the anti-infection and antibacterial fabric for infants according to claim 1, wherein the alkaline catalyst is at least one of sodium carbonate, potassium hydroxide and sodium hydroxide.
6. The method for preparing the infection-preventing antibacterial fabric for the infants according to the claim 1, wherein the molar ratio of the intermediate product, 2- [5- (chloromethyl) -1,2, 4-oxadiazol-3-yl ] -phenol and N, N-dimethylformamide in the step S3 is 1:2 (10-15).
7. The preparation method of the anti-infection and antibacterial fabric for infants according to claim 1, wherein the mass ratio of the ionic polycondensate, the mustard powder and the coupling agent in step S4 is 1:0.1 (0.02-0.05); the coupling agent is at least one of a silane coupling agent KH550, a silane coupling agent KH560 and a silane coupling agent KH 570.
8. The preparation method of the infection-preventing and antibacterial fabric for infants according to claim 1, wherein the extrusion granulation extrusion temperature is 215-225 ℃, and the screw rotation speed is 900-1000 r/min; the melt spinning process comprises the following steps: the spinning temperature is 275 ℃ plus 295 ℃, the spinning speed is 1800 ℃ plus 2400m/min, the drawing temperature is 60-80 ℃, and the total drawing ratio is 1.5-3.5.
9. The preparation method of the infection-preventing and antibacterial fabric for the infants according to claim 1, wherein the mass ratio of the functional yarn to the dimethyl sulfoxide solution of 1, 3-adamantane diacetic acid in the step S5 is 1 (0.05-0.1).
10. An anti-infection and antibacterial fabric for infants prepared by the preparation method of the anti-infection and antibacterial fabric for infants according to any one of claims 1 to 9.
CN202010192918.6A 2020-03-18 2020-03-18 Anti-infection antibacterial fabric for infants and preparation method thereof Withdrawn CN111394868A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010192918.6A CN111394868A (en) 2020-03-18 2020-03-18 Anti-infection antibacterial fabric for infants and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010192918.6A CN111394868A (en) 2020-03-18 2020-03-18 Anti-infection antibacterial fabric for infants and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111394868A true CN111394868A (en) 2020-07-10

Family

ID=71427215

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010192918.6A Withdrawn CN111394868A (en) 2020-03-18 2020-03-18 Anti-infection antibacterial fabric for infants and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111394868A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111945286A (en) * 2020-07-22 2020-11-17 邓生平 Preparation method of antistatic breathable moisture-absorbing fabric
CN117587541A (en) * 2024-01-17 2024-02-23 比音勒芬服饰股份有限公司 Antibacterial polyamide fiber fabric

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111945286A (en) * 2020-07-22 2020-11-17 邓生平 Preparation method of antistatic breathable moisture-absorbing fabric
CN117587541A (en) * 2024-01-17 2024-02-23 比音勒芬服饰股份有限公司 Antibacterial polyamide fiber fabric
CN117587541B (en) * 2024-01-17 2024-04-05 比音勒芬服饰股份有限公司 Antibacterial polyamide fiber fabric

Similar Documents

Publication Publication Date Title
JP7125814B2 (en) Flame-retardant cellulosic fiber and method for preparing same
CN110409012B (en) Antibacterial polyester fiber and preparation method thereof
CN105002630B (en) A kind of distortion-free bamboo fibre bath towel
CN111394868A (en) Anti-infection antibacterial fabric for infants and preparation method thereof
CN113172956A (en) Antibacterial crease-resistant knitted fabric and preparation method thereof
CN110172741B (en) Preparation method of functional cellulose fiber
CN104389049B (en) A kind of chitin modified spandex continuous yarn preparation method
CN113136633B (en) Long-acting antibacterial flame-retardant double-effect lyocell fiber and preparation method thereof
CN109680394A (en) A kind of thermal fabric
CN110656503B (en) Water-absorbing composite silk fabric and processing method thereof
CN111345649A (en) Blanket for infant care and preparation method thereof
CN112048816A (en) Blended fabric of fullerene fibers, polylactic acid fibers and tencel fibers
CN112064181A (en) Soybean protein fiber and graphene-containing synthetic fiber blended knitted fabric
CN108048952A (en) A kind of high resiliency easily bonds the preparation method of puu fiber
CN113123006B (en) Antibacterial comfortable knitted underwear fabric and preparation method thereof
CN108301067B (en) Polylactic acid fiber and preparation method and application thereof
CN107419360A (en) Highly hygroscopic antibacterial chemical fiber wire and preparation method thereof
CN105755573A (en) Method for preparing novel moisture-absorbing, heat-releasing and warming acrylic fibers
CN110306270B (en) Preparation method of moisture-absorbing and breathable three-dimensional composite yarn
CN111286830A (en) Production process of antibacterial textile fabric
KR101716470B1 (en) Dope for spinning lyocell, method for preparing lyocell filament fiber, and lyocell filament fiber prepared therefrom
CN105671684B (en) A kind of manufacture method for the fiber for possessing memory function
CN116397358B (en) Heat-accumulating and heat-preserving acrylic blended yarn, preparation method thereof and application thereof in underwear fabric
CN114575160B (en) Moisture-absorbing antibacterial fabric
CN112323159B (en) Flame-retardant lyocell fiber and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20200710